灭活Covid-19疫苗未损害冻融胚胎移植女性的活产和新生儿结局
该回顾性队列研究纳入2574对计划行冻融胚胎移植的夫妇,比较接种与未接种灭活Covid-19疫苗女性的生殖和新生儿结局。接种组与未接种组的活产率、持续妊娠率、临床妊娠率及新生儿身长和体重均无显著差异。单剂或双剂疫苗以及接种与移植间隔均未显示显著影响。
要点
- 接种灭活Covid-19疫苗未显著影响冻融胚胎移植后的活产率。
- 接种组与未接种组的新生儿出生身长和体重均相似。
- 单剂或双剂疫苗及接种与移植间隔对结局无显著影响。
核心结论
- 灭活Covid-19疫苗未损害计划行冻融胚胎移植女性的活产和新生儿结局。
- 符合条件的个体不应因胚胎移植计划而推迟接种灭活Covid-19疫苗,反之亦然。
研究设计与样本
- 回顾性队列分析,来自一家三级教学医院的生殖医学中心。
- 筛选了2021年3月1日至2021年9月30日期间移植胚胎的2574对夫妇的临床记录和疫苗接种记录以确定 eligibility。
主要发现
- 接种组与未接种组活产率:倾向评分匹配前43.6% vs 45.0%(P=0.590),匹配后42.9% vs 43.9%(P=0.688)。
- 持续妊娠率:匹配前48.2% vs 48.1%(P=0.980),匹配后52.2% vs 52.7%(P=0.875)。
- 临床妊娠率:匹配前55.0% vs 54.8%(P=0.928),匹配后54.7% vs 54.2%(P=0.868)。
- 新生儿出生身长:匹配前50.0±1.6 cm vs 49.0±2.9 cm(P=0.116),匹配后49.9±1.7 cm vs 49.3±2.6 cm(P=0.141)。
- 新生儿出生体重:匹配前3111.2±349.9 g vs 3030.3±588.5 g(P=0.544),匹配后3053.8±372.5 g vs 3039.2±496.8 g(P=0.347)。
关键数值与推荐
- 单剂或双剂疫苗以及接种与胚胎移植的不同间隔对生殖和新生儿结局均未显示显著影响。
临床怎么用
- 符合条件的个体不应因胚胎移植计划而推迟接种灭活Covid-19疫苗,反之亦然。
局限性
- 主要发现可能受回顾性设计限制。
- 数据收集时无法获得三剂Covid-19疫苗接种,因此结果不能反映三剂灭活Covid-19疫苗的安全使用。
- Covid-19感染史基于患者自我报告而非客观实验室检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does inoculation with inactivated vaccines against coronavirus disease 2019 (Covid-19) before frozen-thawed embryo transfer (FET) affect live birth and neonatal outcomes? SUMMARY ANSWER: Inactivated Covid-19 vaccines did not undermine live birth and neonatal outcomes of women planning for FET. WHAT IS KNOWN ALREADY: Accumulating reports are now available indicating the safe use of mRNA vaccines against Covid-19 in pregnant and lactating women, and a few reports indicate that they are not associated with adverse effects on ovarian stimulation or early pregnancy outcomes following IVF. Evidence about the safety of inactivated Covid-19 vaccines is very limited. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort analysis from Reproductive Medical Center of a tertiary teaching hospital. Clinical records and vaccination record of 2574 couples with embryos transferred between 1 March 2021 and 30 September 2021 were screened for eligibility of this study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Clinical and vaccination data of infertile couples planning for FET were screened for eligibility of the study. The reproductive and neonatal outcomes of FET women inoculated with inactivated Covid-19 vaccines or not were compared. The primary outcomes were live birth rate per embryo transfer cycle and newborns' birth height and weight. Secondary outcomes included rates of ongoing pregnancy, clinical pregnancy, biochemical pregnancy and spontaneous miscarriage. Multivariate logistical regression and propensity score matching (PSM) analyses were performed to minimize the influence of confounding factors. Subgroup analyses, including single dose versus double dose of the vaccines and the time intervals between the first vaccination and embryo transfer, were also performed. MAIN RESULTS AND THE ROLE OF CHANCE: Vaccinated women have comparable live birth rates (43.6% versus 45.0% before PSM, P = 0.590; and 42.9% versus 43.9% after PSM, P = 0.688), ongoing pregnancy rates (48.2% versus 48.1% before PSM, P = 0.980; and 52.2% versus 52.7% after PSM, P = 0.875) and clinical pregnancy rate (55.0% versus 54.8% before PSM, P = 0.928; and 54.7% versus 54.2% after PSM, P = 0.868) when compared with unvaccinated counterparts. The newborns' birth length (50.0 ± 1.6 versus 49.0 ± 2.9 cm before PSM, P = 0.116; and 49.9 ± 1.7 versus 49.3 ± 2.6 cm after PSM, P = 0.141) and birth weight (3111.2 ± 349.9 versus 3030.3 ± 588.5 g before PSM, P = 0.544; and 3053.8 ± 372.5 versus 3039.2 ± 496.8 g after PSM, P = 0.347) were all similar between the two groups. Neither single dose nor double dose of vaccines, as well as different intervals between vaccination and embryo transfer showed any significant impacts on reproductive and neonatal outcomes. LIMITATIONS, REASONS FOR CAUTION: The main findings might be limited by retrospective design. Besides, inoculations of triple dose of Covid-19 vaccines were not available by the time of data collection, thus the results cannot reflect the safe use of triple dose of inactivated Covid-19 vaccines. Finally, history of Covid-19 infection was based on patients' self-report rather than objective laboratory tests. WIDER IMPLICATIONS OF THE FINDINGS: Eligible individuals of inactivated vaccines against Covid-19 should not postpone vaccination plan because of their embryo transfer schedule, or vice versa. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Medical Key Discipline of Guangzhou (2021-2023). All authors had nothing to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Cao M, Wu Y, Lin Y, et al. Inactivated Covid-19 vaccine did not undermine live birth and neonatal outcomes of women with frozen-thawed embryo transfer. Hum Reprod. 2022. PMID: 36200874. doi:10.1093/humrep/deac220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。